Found 10 matching trials
Study of S-1 Plus DC-CIK for Patients With Advanced Gastric Cancer
PHASE1The purpose of this study is to evaluate the antitumor effect and safety of...
Location
Capital Medical University Cancer Center
Study of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy
N/ATo investigate gene expression profile and immunological associated analysi...
Location
Capital Medical University Cancer Center/Beijing Shijitan Hospital
Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma
PHASE2The goal of this randomized phase 2 controlled clinical trial is to study s...
Location
Clinical Oncology Department, Ummc
Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer
PHASE1The purpose of this study is to evaluate the antitumor effect and safety of...
Location
Capital Medical University Cancer Center
A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors
PHASE2Main purpose of this study is through comparing with the external control, ...
Location
Sun Yat-sen University Cancer Center
Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer
PHASE2The prognosis of advanced breast cancer does not improve much recently alth...
Status
Active Not Recruiting
Location
Multiple Locations
Safety and Efficacy of Immune Therapy for Condyloma
NACytokine-induced killer (CIK) cells will be co-cultured with HPV induced de...
Location
Shenzhen Second Hospital
The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer
PHASE2As a special type of breast cancer, the triple negative breast cancer has t...
Location
the First Affiliated Hospital of Xi 'an Jiaotong University
Anti-PD-1 Alone or Combined With Autologous Cell Therapy in Advanced NSCLC
PHASE1A randomized controlled study to compared the clinical effects and safety o...
Location
Capital Medical Unvierstiy Cancer Center/ Beijing Shijitan Hospital
Study of DC-CTL Combined With CIK for Advanced Solid Tumor
PHASE1Background: Combinations of Dendritic and Cytokine-induced Killer Cells (DC...
Location
Harbin Medical University Cancer Hospital